Metabolic Biochemistry: Lipid, Amino Acid, Heme, One-Carbon, and Nucleotide Metabolism

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/47

flashcard set

Earn XP

Description and Tags

Vocabulary practice cards defining key enzymes, regulatory factors, transport proteins, pathways, and clinical conditions in metabolic biochemistry (lipid, amino acid, heme, one-carbon, and nucleotide metabolism).

48 Terms

1
New cards

Triglycerides (TAGs)

Primary energy storage molecules in adipose tissue yielding approximately 9 kcal/g9\,\text{kcal/g}, composed of a glycerol backbone esterified to three fatty acid chains via ester linkages, and functioning in thermal insulation and organ cushioning.

2
New cards

Pancreatic Lipase

An enzyme secreted into the intestinal lumen that hydrolyzes dietary triglycerides at the sn-1sn\text{-}1 and sn-3sn\text{-}3 positions (assisted by colipase) to yield 2-monoglycerides2\text{-monoglycerides} (2-MAG2\text{-MAG}) and free fatty acids (FFAs\text{FFAs}).

3
New cards

Lipoprotein Lipase (LPL)

An enzyme anchored to capillary endothelium in adipose and skeletal or cardiac muscle that is activated by ApoC-II\text{ApoC-II} to hydrolyze triglycerides inside circulating chylomicrons and VLDL\text{VLDL} into free fatty acids and glycerol.

4
New cards

Adipose Triglyceride Lipase (ATGL)

The rate-limiting enzyme of the adipocyte intracellular lipolysis cascade that converts triglycerides to diacylglycerol (DAG\text{DAG}) and one free fatty acid; it is transcriptionally regulated by PPARγ\text{PPAR}\gamma and directly activated by the cofactor CGI-58\text{CGI-58}.

5
New cards

Hormone-Sensitive Lipase (HSL)

An adipocyte enzyme that converts diacylglycerol (DAG\text{DAG}) to monoacylglycerol (MAG\text{MAG}) and one free fatty acid; it is activated by PKA\text{PKA}-dependent phosphorylation (stimulated by catecholamines, glucagon, and ACTH\text{ACTH}) and inactivated via dephosphorylation stimulated by insulin.

6
New cards

Monoglyceride Lipase (MGL)

The terminal enzyme of the intracellular adipocyte lipolysis cascade that cleaves monoacylglycerol (MAG\text{MAG}) into glycerol and one free fatty acid.

7
New cards

HMG-CoA Reductase

The rate-limiting enzyme of cholesterol biosynthesis located in the cytoplasm/ER that converts HMG-CoA\text{HMG-CoA} to mevalonate; it is transcriptionally upregulated by SREBP2\text{SREBP2}, activated via dephosphorylation by insulin, and inhibited via phosphorylation by AMPK\text{AMPK} or glucagon.

8
New cards

SREBP2 (Sterol Regulatory Element-Binding Protein 2)

A sterol-sensing transcription factor that is escorted by SCAP\text{SCAP} from the ER to the Golgi when intracellular sterols are low, where it undergoes proteolytic cleavage so its active N-terminal domain can enter the nucleus and bind sterol regulatory elements (SREs\text{SREs}) to upregulate transcription of HMG-CoA\text{HMG-CoA} reductase and the LDL\text{LDL} receptor.

9
New cards

LCAT (Lecithin:Cholesterol Acyltransferase)

A plasma enzyme bound to HDL\text{HDL} that is activated by ApoA-I\text{ApoA-I} to transfer a fatty acid from phosphatidylcholine (lecithin) to free cholesterol, generating hydrophobic cholesteryl esters for reverse cholesterol transport.

10
New cards

ACAT (Acyl-CoA:Cholesterol Acyltransferase)

An intracellular enzyme that synthesizes cholesteryl esters from free cholesterol and fatty acyl-CoA for intracellular lipid droplet storage.

11
New cards

Cholesterol 7α-Hydroxylase (CYP7A1)

The rate-limiting microsomal enzyme in the synthesis of primary bile acids (cholic acid and chenodeoxycholic acid) from cholesterol, serving as the primary pathway for cholesterol excretion.

12
New cards

Statins

A class of competitive inhibitors of HMG-CoA\text{HMG-CoA} reductase (e.g., lovastatin, atorvastatin) structured to mimic the HMG-CoA/mevalonate\text{HMG-CoA/mevalonate} transition state, thereby depleting hepatocyte cholesterol and triggering SREBP2\text{SREBP2}-mediated upregulation of cell-surface LDL\text{LDL} receptors to enhance plasma LDL-C\text{LDL-C} clearance.

13
New cards

Chylomicrons

The lowest-density (<0.95 g/mL< 0.95\,\text{g/mL}) lipoproteins synthesized by enterocytes, containing approximately 90%90\% dietary triglycerides along with apoproteins B-48\text{B-48}, A-I\text{A-I}, C-II\text{C-II}, and E\text{E}, which transport dietary lipids to peripheral tissues.

14
New cards

VLDL (Very Low-Density Lipoprotein)

A liver-derived lipoprotein (density 0.95–1.006 g/mL0.95\text{--}1.006\,\text{g/mL}) consisting of approximately 60%60\% endogenous triglycerides and apoproteins B-100\text{B-100}, C-II\text{C-II}, and E\text{E} that transports liver-synthesized triglycerides to peripheral tissues.

15
New cards

IDL (Intermediate-Density Lipoprotein)

A transient lipoprotein remnant of VLDL\text{VLDL} metabolism (density 1.006–1.019 g/mL1.006\text{--}1.019\,\text{g/mL}) enriched in triglycerides and cholesteryl esters and bearing apoproteins B-100\text{B-100} and E\text{E}, which is either cleared directly by the liver or converted by hepatic lipase into LDL\text{LDL}.

16
New cards

LDL (Low-Density Lipoprotein)

A cholesterol-rich lipoprotein (density 1.019–1.063 g/mL1.019\text{--}1.063\,\text{g/mL}) composed of approximately 50%50\% cholesteryl esters and apoprotein B-100\text{B-100} that delivers cholesterol to peripheral tissues and the liver via receptor-mediated endocytosis.

17
New cards

HDL (High-Density Lipoprotein)

The highest-density (1.063–1.210 g/mL1.063\text{--}1.210\,\text{g/mL}) lipoprotein composed of phospholipids, cholesteryl esters, and approximately 50%50\% protein (carrying A-I\text{A-I}, A-II\text{A-II}, C\text{C}, and E\text{E} apoproteins), which mediates reverse cholesterol transport and acts as a circulating apoprotein reservoir.

18
New cards

ApoC-II

An exchangeable apoprotein transferred from HDL\text{HDL} to chylomicrons and VLDL\text{VLDL} that acts as the essential cofactor required to activate lipoprotein lipase (LPL\text{LPL}) on capillary endothelium.

19
New cards

ApoE

An apoprotein present on chylomicrons, VLDL\text{VLDL}, IDL\text{IDL}, and HDL\text{HDL} that mediates high-affinity binding to hepatic remnant receptors to trigger endocytic clearance of lipoprotein remnants by the liver.

20
New cards

PCSK9

A regulatory protein that binds cell-surface LDL\text{LDL} receptors and targets them for lysosomal degradation rather than allowing endosomal recycling back to the plasma membrane.

21
New cards

Familial Hypercholesterolemia (FH)

An autosomal dominant disorder caused primarily by loss-of-function mutations in the LDLR\text{LDLR} gene (or mutations in APOB\text{APOB} or gain-of-function PCSK9\text{PCSK9}), resulting in impaired clearance of plasma LDL-C\text{LDL-C}, xanthomas, corneal arcus, and premature atherosclerosis via macrophage foam cell formation.

22
New cards

Nitrogen Balance

The physiological relationship between nitrogen intake and excretion, categorized as equilibrium in healthy adults, positive (intake exceeding excretion) during growth, pregnancy, and recovery, or negative (excretion exceeding intake) during starvation, burns, trauma, or sepsis.

23
New cards

Pyridoxal Phosphate (PLP)

The active coenzyme form of vitamin B6\text{B}_6 that forms a Schiff base intermediate with amino acids to transiently hold amino groups as pyridoxamine phosphate (PMP\text{PMP}) during aminotransferase-catalyzed transamination reactions.

24
New cards

Carbamoyl Phosphate Synthetase I (CPS-I)

The rate-limiting mitochondrial enzyme of the urea cycle that condenses free NH4+\text{NH}_4^+, HCO3−\text{HCO}_3^-, and 2 ATP2\,\text{ATP} into carbamoyl phosphate; it requires N-acetylglutamateN\text{-acetylglutamate} (NAG\text{NAG}) as an obligatory allosteric activator.

25
New cards

N-Acetylglutamate (NAG)

An obligatory short-term allosteric activator of carbamoyl phosphate synthetase I (CPS-I\text{CPS-I}), synthesized by NAG\text{NAG} synthase in response to elevated arginine, glutamate, and acetyl-CoA concentrations.

26
New cards

Ornithine Transcarbamoylase (OTC)

A mitochondrial urea cycle enzyme that condenses carbamoyl phosphate with ornithine to synthesize citrulline, which is subsequently transported into the cytosol.

27
New cards

Glutamate Dehydrogenase

A mitochondrial enzyme in the liver and kidney that catalyzes the oxidative deamination of glutamate to regenerate α-ketoglutarate\alpha\text{-ketoglutarate} and release free NH4+\text{NH}_4^+ using NAD+\text{NAD}^+ (or amination using NADPH\text{NADPH}); it is inhibited by ATP/GTP\text{ATP/GTP} and activated by ADP/GDP\text{ADP/GDP}.

28
New cards

Transdeamination

The coupled metabolic pathway wherein transamination transfers α-amino\alpha\text{-amino} groups from various amino acids to α-ketoglutarate\alpha\text{-ketoglutarate} to form glutamate, followed by oxidative deamination of glutamate to release free ammonia for urea synthesis.

29
New cards

S-Adenosylmethionine (SAM)

The universal activated methyl donor formed from methionine and ATP\text{ATP}, which is converted into S-adenosylhomocysteineS\text{-adenosylhomocysteine} (SAH\text{SAH}) upon transfer of its methyl group during biological transmethylation reactions.

30
New cards

Phenylketonuria (PKU)

An inherited amino acid disorder caused by a deficiency in phenylalanine hydroxylase (or its tetrahydrobiopterin coenzyme, BH4\text{BH}_4), leading to accumulation of phenylalanine and phenylketones, intellectual disability if untreated, hypopigmentation, and a characteristic musty body odor.

31
New cards

Maple Syrup Urine Disease (MSUD)

An inborn error of metabolism caused by a deficiency in the branched-chain α-ketoacid\alpha\text{-ketoacid} dehydrogenase complex, leading to neurotoxic accumulation of leucine, isoleucine, valine, and their respective α-ketoacids\alpha\text{-ketoacids}, presenting with poor feeding, encephalopathy, and a burnt-sugar urine odor.

32
New cards

Homocystinuria

An inherited metabolic disorder caused by deficiency of cystathionine β-synthase\beta\text{-synthase}, resulting in the accumulation of homocysteine and methionine, and characterized by thromboembolism, downward lens dislocation (ectopia lentis), and a marfanoid habitus.

33
New cards

Alkaptonuria

An inborn error of amino acid metabolism caused by deficiency of homogentisate 1,2-dioxygenase1{,}2\text{-dioxygenase}, causing accumulation of homogentisic acid, urine that darkens to black upon standing, ochronosis (blue-black cartilage pigmentation), and severe debilitating arthritis.

34
New cards

ALA Synthase (ALAS)

The committed and rate-limiting mitochondrial enzyme of heme biosynthesis that condenses glycine and succinyl-CoA into 5-aminolevulinic acid5\text{-aminolevulinic acid} using PLP\text{PLP}; it exists as hepatic housekeeping ALAS1\text{ALAS1} (feedback-repressed by heme/hemin) and erythroid-specific ALAS2\text{ALAS2} (regulated by iron availability).

35
New cards

UDP-Glucuronosyltransferase (UGT1A1)

A microsomal hepatocyte enzyme that conjugates two glucuronic acid molecules to hydrophobic unconjugated bilirubin, converting it to water-soluble bilirubin diglucuronide (direct conjugated bilirubin) for biliary secretion.

36
New cards

Porphyrias

A group of inherited disorders caused by partial deficiencies in enzymes of the heme biosynthetic pathway, in which accumulation of early non-cyclic intermediates (e.g., ALA\text{ALA}, PBG\text{PBG}) produces neurovisceral symptoms and accumulation of later porphyrinogens produces cutaneous photosensitivity.

37
New cards

Tetrahydrofolate (THF / FH4)

The metabolically active, fully reduced coenzyme form of folate synthesized by dihydrofolate reductase (DHFR\text{DHFR}), which acts as an essential carrier of one-carbon units at multiple oxidation states attached to N5N^5, N10N^{10}, or both.

38
New cards

Thymidylate Synthase

An enzyme that catalyzes the transfer and reduction of a one-carbon unit from N5,N10-methylene-THFN^5,N^{10}\text{-methylene-THF} to dUMP\text{dUMP} to form dTMP\text{dTMP}, while oxidizing THF\text{THF} to dihydrofolate (FH2\text{FH}_2).

39
New cards

Folate Trap

A functional folate deficiency resulting from vitamin B12\text{B}_{12} deficiency, wherein inability of methionine synthase to transfer the methyl group from N5-methyl-THFN^5\text{-methyl-THF} causes irreversible accumulation and trapping of folate as N5-methyl-THFN^5\text{-methyl-THF}, impairing purine and dTMP\text{dTMP} synthesis.

40
New cards

Methotrexate (MTX)

A synthetic folate analog and antimetabolite drug that competitively inhibits human dihydrofolate reductase (DHFR\text{DHFR}), depleting FH4\text{FH}_4 and halting dTMP\text{dTMP} and purine synthesis in rapidly dividing cells.

41
New cards

5-Fluorouracil (5-FU)

A pyrimidine antimetabolite drug metabolized into FdUMP\text{FdUMP}, which acts as an irreversible suicide inhibitor of thymidylate synthase, depleting dTMP\text{dTMP} pools and blocking DNA replication.

42
New cards

Glutamine Phosphoribosyl Amidotransferase

The committed-step enzyme of de novo purine nucleotide synthesis that reacts PRPP\text{PRPP} with glutamine to form 5′-phosphoribosyl 1’-amine5'\text{-phosphoribosyl 1'-amine}; it is synergistically feedback-inhibited by AMP\text{AMP} and GMP\text{GMP}.

43
New cards

HGPRT (Hypoxanthine-Guanine Phosphoribosyltransferase)

A key purine salvage enzyme that transfers a phosphoribosyl group from PRPP\text{PRPP} to hypoxanthine or guanine to reform IMP\text{IMP} or GMP\text{GMP}, respectively.

44
New cards

Carbamoyl Phosphate Synthetase II (CPS-II)

The cytosolic, committed-step enzyme of pyrimidine de novo synthesis that condenses glutamine, CO2\text{CO}_2, and 2 ATP2\,\text{ATP} to form carbamoyl phosphate; it is allosterically inhibited by UTP\text{UTP} and activated by PRPP\text{PRPP} and ATP\text{ATP}.

45
New cards

Ribonucleotide Reductase (RR)

An enzyme that reduces ribonucleoside diphosphates (NDPs\text{NDPs}: ADP\text{ADP}, GDP\text{GDP}, CDP\text{CDP}, UDP\text{UDP}) directly into deoxyribonucleoside diphosphates (dNDPs\text{dNDPs}) at the 2′2' carbon using the redox protein cofactor thioredoxin.

46
New cards

Xanthine Oxidase

An enzyme in purine catabolism that sequentially oxidizes hypoxanthine to xanthine, and xanthine to uric acid, the poorly soluble final excretory product of purine degradation in humans.

47
New cards

Lesch-Nyhan Syndrome

An X-linked recessive disorder caused by complete deficiency of HGPRT\text{HGPRT}, resulting in purine salvage failure, accumulation of intracellular PRPP\text{PRPP}, hyperuricemia/gout, dystonia, intellectual disability, and compulsive self-mutilation.

48
New cards

Allopurinol

A structural hypoxanthine analog that inhibits xanthine oxidase (metabolized to the suicide inhibitor oxypurinol/alloxanthine), reducing uric acid production while increasing the excretion of more soluble hypoxanthine and xanthine.